Evaluation of a pseudo-ceramide containing formulatio

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000042427
• Lead Sponsor: Kao Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-11-16
• Study Completion: 2020-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: Female
• Target Recruitment: 55

Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects who are pregnancy, lactation, or subjects who may become pregnant very soon. 2.Subjects with serious underlying diseases. 3.Subjects who have clear skin symptoms at the test site. 4.Subjects who are currently undergoing hospital treatment with atopic dermatitis 5.Subjects who have had atopic dermatitis symptoms in their face within the present or past year 6.Subjects who are currently treating the skin of the face 7.Subjects who are currently using external drugs (prescription drugs, over-the-counter drugs) on the skin of the face 8.Subjects who are currently participating in product monitor surveys involving testing of the use of other drugs or with the use of quasi-drugs, cosmetics, and facial devices 9.Subjects who are determined to be not appropriate by investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of transepidermal water loss, stratum corneum water content and dermatological assessment after treatments for 1 or 2 weeks.

Secondary Outcome Measures

Name	Time	Method
Evaluation of the skin surface images, questionnaire survey and VAS after treatments for 1 or 2 weeks.